This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
14 Mar 2022 | North America | Market Outlook
Next-generation Diagnostics Outlook, 2022
Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth
In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...
$4,950.00 -
08 Mar 2022 | North America | Market Outlook
Global Pharmaceuticals Outlook, 2022
The Digitalization of the Pharmaceuticals Value Chain is Opening up New Growth Opportunities for Stakeholders
Frost & Sullivan offers an outlook for the global pharmaceuticals market for 2022-2026, including emerging trends and growth opportunities. Prioritizing booster doses over initial dose coverage is negatively impacting the global mitigation of the COVID-19 pandemic, which is resulting in severe implications on health and social and economic well-bei...
$4,950.00 -
30 Apr 2021 | North America | Tracker
US COVID-19 Vaccines and Therapeutics Tracker—Market Insights and Trends, H1 2021
Agnostic Vaccine Platform Technology Enhancing Future Growth Potential of Participants in the Value Chain
This study by Frost & Sullivans Healthcare and Life Sciences team provides critical insights into the US COVID-19 vaccines and therapeutics market, including developing vaccines, supply chain considerations, and requirements to manage distribution. The study also identifies actionable and profitable growth opportunities for industry participants. T...
$2,450.00 -
09 Apr 2018 | North America | Market Outlook
Global Life Sciences Industry Outlook, 2018
Global Life Sciences Industry to Reach $1.5 T by 2022, Driven by Innovative Google, Amazon, Facebook, Apple (GAFA) Partnerships and R&D IT Investments
The global life sciences industry is onto a rocking start with the surge in CEO confidence from US tax reforms, rollicking equity markets and strengthening the global economy. Healthcare digitization, democratization creating explosion in patient data, emergence of value-based reimbursement models, and healthcare consumerism shifting the risk from ...
$4,950.00 -
15 Dec 2014 | North America | Market Outlook
Next-generation Healthcare - Global Advanced Medical Technologies 2014
Disruptions and Transformations are Shaping the Future of Healthcare Delivery
This study analyzes trends impacting the future of healthcare delivery and market participants. Market solutions are transitioning from models suited to older citizens for use type service models toward business models built around value and quality of service. Companies with solutions around specific procedures or treatments could see attrition as...
$3,950.00 -
11 Jul 2013 | North America | Tracker
2012 United States Radiology Directors’ Choice: Medical Imaging Equipment
Determining Brand Perceptions and Preferences
The primary objective of this research is to assess the behavior of North American radiology directors as well as their preferences regarding radiology departments use of medical imaging equipment and services. Supporting the primary objective, this research will also: determine titles of medical equipment purchasers (executives, directors, and man...
$10,000.00 -
10 May 2013 | North America | Tracker
U.S. Medical Imaging IT Middleware
A Study of Customer Perceptions and Purchase Intentions in Hospitals
This is a repackaging of this research deliverable. During the fourth quarter of 2009, Frost & Sullivan conducted a Customer Research project titled Medical Imaging IT Middleware: A Study of Customer Perceptions and Purchase Intentions in the U.S. Hospital Market. The study aimed to provide the vendors developing, selling, and implementing medical ...
$10,000.00
